Estimating the cardiovascular benefits of DPP-4 inhibitors: a simulated study PCV15 C. Andy Schuetz1, Tina Yeung1, Matthias Blüher2, Siew Hwa Ong3

First Page		Document Content
Date: 2013-11-21 17:58:56 Endocrine system Anti-diabetic drugs Dipeptidyl peptidase-4 inhibitors Amides Alcohols Anti-diabetic medication Saxagliptin Metformin Diabetes mellitus type 2 Chemistry Diabetes Organic chemistry		Estimating the cardiovascular benefits of DPP-4 inhibitors: a simulated study PCV15 C. Andy Schuetz1, Tina Yeung1, Matthias Blüher2, Siew Hwa Ong3 Add to Reading List Source URL: archimedesmodel.com Download Document from Source Website File Size: 368,02 KB Share Document on Facebook

	C:uments and Settingsyandktoprmacists Bulletin July 2015.wpd DocID: 1qQog - View Document
	SPECIAL AUTHORIZATION REQUEST DPP-4/SGLT2 INHIBITORS Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 – PRESCRIBER INFORMATION DocID: 1pr3h - View Document
	Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES DocID: 1oY1K - View Document
	Patient Information JANUVIA™ (jah-NEW-vee-ah) (sitagliptin) Tablets Read the Patient Information that comes with JANUVIA* before you start taking it and each time you get a refill. There may be new information. This le DocID: 1anBo - View Document
	g iF F5t+ Erlft [9.tr Et [+ Govemo da Regiio AdministrativaEspecialde Macau 6i+.tr DocID: 17KbB - View Document